• MJardin Group (MJAR) has shipped its first load of recreational cannabis to the province of Alberta
  • The shipment included several different strands produced by the company
  • Alberta is home to nearly half the legal cannabis stores in the country
  • Alberta has the largest proportion of experienced cannabis users
  • MJardin Group is up 4.55 per cent on the day, with shares of the company trading at C$0.12 at 9:30 am ET

MJardin Group (MJAR) has shipped its first load of recreational cannabis to the province of Alberta.

The shipment included several different strands produced by the company.

Alberta is home to nearly half the legal cannabis stores in the country, and has captured the second-highest sales of legal cannabis in Canada, overtaking British Columbia, and second only to Ontario.

Alberta has the largest proportion of experienced cannabis users, shifting customer expectation towards mature products and forcing cannabis brands to get on board with broader trends in consumer-packaged goods. Certain trends, along with strategic innovation and portfolio optimization, have helped brands stand out in this evolving province.

“We are delighted that our cannabis brands will now be available to consumers in the province of Alberta – Canada’s second largest recreational cannabis market. Across Canada we are seeing customers migrate from the black market to the legal market, and as competitors come into the market, we continue to re-evaluate our offering to ensure we are exceeding industry expectations,” said MJardin Group CEO Pat Witcher.

MJardin Group has headquarters in Toronto, Ontario and Denver, Colorado. The company’s mission is to set the standard for successful ownership of assets in the cannabis industry.

MJardin Group is up 4.55 per cent on the day, with shares of the company trading at C$0.12 at 9:30 am ET.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.